更正：具有增殖潜力的基因工程化气体囊泡蛋白用于协同靶向肿瘤治疗。
Correction: Genetically engineered gas vesicle proteins with proliferative potential for synergistic targeted tumor therapy.
作者信息
Lin Li, Du Yan, Wang Yaotai, Luo Yong, Jiang Fujie, Yang Haiyan, Ren Li, Zou Jianzhong
机构信息
State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University Chongqing 400016 China
Department of Ultrasound Medicine, Chongqing Shapingba Hospital, School of Medicine, Chongqing University Chongqing 400033 China.
出版信息
RSC Adv. 2025 Jan 17;15(3):1576. doi: 10.1039/d5ra90006a. eCollection 2025 Jan 16.
Abstract
[This corrects the article DOI: 10.1039/D4RA07532C.].
摘要
[本文更正了文章的数字对象标识符：10.1039/D4RA07532C。]
相似文献
1
Correction: Genetically engineered gas vesicle proteins with proliferative potential for synergistic targeted tumor therapy.更正：具有增殖潜力的基因工程化气体囊泡蛋白用于协同靶向肿瘤治疗。
RSC Adv. 2025 Jan 17;15(3):1576. doi: 10.1039/d5ra90006a. eCollection 2025 Jan 16.
2
Genetically engineered gas vesicle proteins with proliferative potential for synergistic targeted tumor therapy.具有增殖潜力的基因工程化气体囊泡蛋白用于协同靶向肿瘤治疗。
RSC Adv. 2025 Jan 2;15(1):157-166. doi: 10.1039/d4ra07532c.
3
Genetically engineered bacteria-mediated multi-functional nanoparticles for synergistic tumor-targeting therapy.基因工程菌介导的多功能纳米颗粒用于协同肿瘤靶向治疗。
Acta Biomater. 2022 Sep 15;150:337-352. doi: 10.1016/j.actbio.2022.07.056. Epub 2022 Aug 2.
4
Correction.更正。
Open Forum Infect Dis. 2024 May 10;11(5):ofae247. doi: 10.1093/ofid/ofae247. eCollection 2024 May.
5
Erratum: Publisher Correction to Volume 1 (2016).勘误：《第1卷（2016年）》的出版商更正。
EJNMMI Radiopharm Chem. 2018 Nov 26;3:13. doi: 10.1186/s41181-018-0049-9. eCollection 2018 Dec.
6
Erratum: Publisher Correction to: Multiple articles in Food Science and Biotechnology.勘误：《食品科学与生物技术》多篇文章的出版商更正。
Food Sci Biotechnol. 2018 Jun 12;27(4):1245. doi: 10.1007/s10068-018-0398-x. eCollection 2018 Aug.
7
Correction to , Volume 6, Issue Supplement 1, 2022.对《第6卷，2022年第1期增刊》的勘误
J Endocr Soc. 2023 Apr 5;6(Suppl 1):bvad033. doi: 10.1210/jendso/bvad033. eCollection 2022 Nov 1.
8
Correction to: Volume 2 Issue 1 of .对《……》第2卷第1期的勘误
PNAS Nexus. 2023 Jan 27;2(1):pgad016. doi: 10.1093/pnasnexus/pgad016. eCollection 2023 Jan.
9
Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.更正：在两种施万细胞瘤基因工程小鼠模型中共同靶向丝裂原活化蛋白激酶（MAPK）和磷脂酰肌醇-3激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白（PI3K/AKT/mTOR）信号通路可降低肿瘤分级和肿瘤数量。
Oncotarget. 2020 Sep 29;11(39):3618-3620. doi: 10.18632/oncotarget.27349.
10
Erratum: Publisher Correction: articles initially published in wrong volume.勘误：出版商更正：文章最初发表于错误卷期。
Cell Death Discov. 2019 Jul 10;5:116. doi: 10.1038/s41420-019-0186-2. eCollection 2019.
Zotero 插件